Ask A Lawyer

Tell Us Your Case Information for Fastest Lawyer Match!

Please include all relevant details from your case including where, when, and who it involves.
Case details that can effectively describe the legal situation while also staying concise generally receive the best responses from lawyers.


By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages, Terms of Use, and Privacy Policy. Information provided may not be privileged or confidential.

R. Todd Ingram

R. Ingram Lawyer

R. Todd Ingram update listing

Criminal, Litigation, Personal Injury

(Please indicate if you do not want referral sent to multiple lawyers.)

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages, Terms of Use, and Privacy Policy. Information provided may not be privileged or confidential.
School Degree Major Graduation
University of Denver College of Law Juris Doctorate Law School N/A
Pennsylvania State University Bachelor of Science N/A N/A N/A
State / Court Date
Wyoming N/A
U.S. District Court District of Wyoming N/A
U.S. District Court District of Colorado N/A
U.S. Court of Appeals 10th Circuit N/A
U.S. Bankruptcy Court Wyoming N/A
U.S. Bankruptcy Court Colorado N/A
Colorado N/A

Service Type:Private


MAIN LOCATION

130 North Ash, Suite 200
Casper, WY 82601

SAMPLE LEGAL CASES

Over 200 Families Have Filed Zofran Lawsuits
As of February 16, 2016, 224 Zofran lawsuits have been consolidated in the U.S. District Court for Massachusetts. Each of these complaints accuses GlaxoSmithKline, the makers of Zofran, of promoting their drug for non-FDA approved uses and of concealing evidence of Zofran’s link to birth defects.
Child Custody: Waiting for the Other Shoe to Drop
Is the UCCJEA jurisdictional provision permitting jurisdiction over custody cases even if parents don't have minimum contacts with the forum State Unconstitutional?
Over 200 Families Have Filed Zofran Lawsuits
As of February 16, 2016, 224 Zofran lawsuits have been consolidated in the U.S. District Court for Massachusetts. Each of these complaints accuses GlaxoSmithKline, the makers of Zofran, of promoting their drug for non-FDA approved uses and of concealing evidence of Zofran’s link to birth defects.